Jay Moorin's Trading History
| AGRXAgile Therapeutics | Jan 29, 2016 | ― | Informative Buy | 2.50M | $7.64M | |
| EGRXEagle Pharmaceuticals | Feb 20, 2014 | Director, Ten Percent Owner | Uninformative Buy | ― | $73.49K | |
| ~ACHNAchillion Pharmaceuticals | Dec 18, 2009 | ― | Informative Sell | 1.96M | $18.01M | |
| AVNRAvanir Pharmaceuticals | Oct 13, 2009 | ― | Informative Sell | 4.11M | ― | |
| PRTKParatek Pharmaceuticals | ― | ― | ― | $8.27M |
You May Also Like
Jay Moorin insider profile FAQ
What is the percentage of profitable transactions made by Jay Moorin?
The percentage of profitable transactions made by Jay Moorin is 67%.
What is the average return per transaction made by Jay Moorin?
The average return per transaction made by Jay Moorin is 164.80%.
What stocks does Jay Moorin hold?
Jay Moorin holds: EGRX, AGRX, ~ACHN, AVNR, PRTK stocks.
What was Jay Moorin’s latest transaction?
Jay Moorin’s latest transaction was an Informative Buy of $2.50M.
What was Jay Moorin's most profitable transaction?
Jay Moorin’s most profitable transaction was an Informative Buy of AGRX stock on May 22, 2014. The return on the trade was 800.00%.
What is Jay Moorin's role in Eagle Pharmaceuticals?
Jay Moorin's role in Eagle Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
